Boston Scientific

Boston Scientific's reported carbon emissions

Boston Scientific, a US-based company in the Electromedical and Electrotherapeutic Apparatus Manufacturing sector, reported a total of approximately 1.78 billion kg CO2e in emissions for 2024. This figure encompasses Scope 1, Scope 2, and Scope 3 emissions. For Scope 1, Boston Scientific's emissions amounted to approximately 87.6 million kg CO2e in 2024. Scope 2 emissions, using the market-based approach, were about 9.9 million kg CO2e, while the location-based figures were approximately 112.9 million kg CO2e. In 2024, Scope 3 emissions were significantly higher, totalling approximately 1.66 billion kg CO2e. The largest contributors within Scope 3 were purchased goods and services, accounting for about 947 million kg CO2e, followed by upstream transportation and distribution at approximately 201.2 million kg CO2e, and business travel at approximately 123.9 million kg CO2e. The company has established ambitious climate commitments. Boston Scientific has committed to achieving net-zero greenhouse gas emissions across its value chain by 2050, with a base year of 2019. Near-term targets include a 46.2% absolute reduction in Scope 1 and 2 GHG emissions by 2030, from the 2019 baseline. Additionally, the company aims for a 55% reduction in Scope 3 GHG emissions per USD value added by 2030, also from a 2019 base year. Long-term targets include a 97% reduction in Scope 1 and 2 GHG emissions per USD value added by 2050, which equates to a 90% absolute reduction. Scope 3 GHG emissions are also targeted for a 97% reduction per USD value added by 2050. Boston Scientific has also pledged to achieve carbon neutrality in its manufacturing and key distribution sites by 2030.